BW
BIIB icon

Basepoint Wealth’s Biogen BIIB Stock Holding History

Basepoint Wealth’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$232K Sell
1,074
-104
-9% -$19.9K 0.13% 96
2026
Q1 		$216K Buy
1,178
+14
+1% +$2.58K 0.12% 99
2025
Q4 		$205K Buy
+1,164
New +$190K 0.12% 95
2025
Q1 		– Sell
-1,590
Closed -$243K – 104
2024
Q4 		$243K Sell
1,590
-347
-18% -$58.5K 0.19% 88
2024
Q3 		$376K Sell
1,937
-291
-13% -$60.9K 0.28% 70
2024
Q2 		$517K Sell
2,228
-356
-14% -$77.4K 0.41% 60
2024
Q1 		$557K Sell
2,584
-95
-4% -$22.2K 0.42% 60
2023
Q4 		$693K Sell
2,679
-101
-4% -$24.8K 0.56% 46
2023
Q3 		$714K Sell
2,780
-24
-0.9% -$6.42K 0.58% 41
2023
Q2 		$799K Sell
2,804
-16
-0.6% -$4.76K 0.66% 41
2023
Q1 		$784K Sell
2,820
-105
-4% -$29.1K 0.65% 40
2022
Q4 		$810K Sell
2,925
-75
-3% -$21.2K 0.72% 36
2022
Q3 		$801K Sell
3,000
-42
-1% -$8.92K 0.85% 25
2022
Q2 		$620K Sell
3,042
-185
-6% -$37.8K 0.65% 37
2022
Q1 		$680K Sell
3,227
-385
-11% -$83.7K 0.63% 29
2021
Q4 		$867K Buy
+3,612
New +$929K 0.85% 24

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Basepoint Wealth's BIIB Position: Q2 2026 in Review

Basepoint Wealth reduced its Biogen (BIIB) stake by 8.8% in Q2 2026, selling an estimated $19.9K and leaving 1,074 shares worth $232K. The position accounts for 0.13% of the portfolio, ranked #96.

Basepoint Wealth first reported a position in BIIB in Q4 2021 and has held it in 16 quarters since. The position peaked at $867K in Q4 2021. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Basepoint Wealth held 1,074 shares of Biogen worth $232K as of Q2 2026.
  • Basepoint Wealth sold 104 Biogen shares in Q2 2026, an estimated $19.9K.
  • Biogen made up 0.13% of Basepoint Wealth's portfolio in Q2 2026, its #96 holding.
  • Basepoint Wealth first reported a position in Biogen in Q4 2021 and has held it in 16 quarters since.
  • Basepoint Wealth's Biogen position peaked at $867K in Q4 2021.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Basepoint Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.